angiotensin ii has been researched along with lu 135252 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, M; d'Uscio, LV; Lüscher, TF; Moreau, P; Shaw, S; Takase, H | 1 |
| Barton, M; d'Uscio, LV; Lüscher, TF; Moreau, P; Shaw, S | 2 |
| Benedetti, G; Benigni, A; Corna, D; Maffi, R; Remuzzi, G; Zoja, C | 1 |
| Berthold, H; Ehmke, H; Just, A; Kirchheim, HR | 1 |
| Barton, M; Carmona, R; d'Uscio, LV; Goettsch, W; Haudenschild, CC; Hillen, H; Krieger, JE; Lattmann, T; Lüscher, TF; Morawietz, H; Münter, K; Shaw, S | 1 |
| Bohlender, J; Dietz, R; Gerbaulet, S; Gross, M; Kirchengast, M; Krämer, J | 1 |
| Henrion, D; Lévy, BI; Matrougui, K | 1 |
| Boemke, W; Hocher, B; Kaczmarczyk, G; Krebs, MO; Schleyer, N | 1 |
| Cernacek, P; Dao, HH; de Champlain, J; Larivière, R; Martens, FM; Moreau, P; Yamaguchi, N | 1 |
| Ehmke, H; Faulhaber, J; Moser, L; Wiesner, RJ | 1 |
| Epelde, F; Heras, M; Pérez-Villa, F; Rigol, M; Roig, E; Roqué, M; Sanz, G; Solanes, N | 1 |
| Bührmann, S; Lückebergfeld, B; Mitchell, A; Nürnberger, J; Philipp, T; Rushentsova, U; Schäfers, RF; Siffert, W; Wenzel, RR | 1 |
1 trial(s) available for angiotensin ii and lu 135252
| Article | Year |
|---|---|
Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism.
Topics: Adult; Angiotensin II; Blood Pressure; Cross-Over Studies; Double-Blind Method; Endothelin A Receptor Antagonists; Endothelins; Female; Genotype; Hand; Hemodynamics; Heterotrimeric GTP-Binding Proteins; Humans; Male; Microcirculation; Neurotransmitter Agents; Phenylpropionates; Polymorphism, Genetic; Pyrimidines; Regional Blood Flow; Renin-Angiotensin System; Skin | 2004 |
12 other study(ies) available for angiotensin ii and lu 135252
| Article | Year |
|---|---|
Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist.
Topics: Angiotensin II; Animals; Arteries; Basilar Artery; Blood Pressure; Endothelin Receptor Antagonists; Endothelins; Hypertrophy; Mesenteric Arteries; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred WKY; Receptor, Endothelin A | 1997 |
Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation.
Topics: Angiotensin II; Animals; Aorta; Aspartic Acid Endopeptidases; Blood Pressure; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Femoral Artery; In Vitro Techniques; Iodine Radioisotopes; Kidney; Male; Metalloendopeptidases; Muscle Contraction; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred WKY; Receptor, Endothelin A; Receptors, Endothelin | 1997 |
Differential modulation of the renal and myocardial endothelin system by angiotensin II in Vivo. Effects of chronic selective ETA receptor blockade.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Endothelin Receptor Antagonists; Endothelin-1; Heart; Kidney; Male; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred WKY; Receptor, Endothelin A | 1998 |
Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.
Topics: Angiotensin II; Animals; Blood Pressure; Endothelin-1; Glomerulonephritis; Indoles; Kidney; Male; Phenylpropionates; Proteinuria; Pyrimidines; Rats; Rats, Sprague-Dawley | 1998 |
Interaction between nitric oxide and endogenous vasoconstrictors in control of renal blood flow.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dogs; Drug Interactions; Endothelin Receptor Antagonists; Enzyme Inhibitors; Female; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Penicillamine; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Renal Circulation; Vasoconstrictor Agents | 1999 |
Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Carotid Arteries; Cholesterol; Cyclooxygenase Inhibitors; Diet; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression Regulation, Enzymologic; Humans; Indomethacin; Kidney; Lung; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Culture Techniques; Peptidyl-Dipeptidase A; Phenylpropionates; Protein Binding; Pyrimidines; Receptor, Endothelin A; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2000 |
Synergistic effects of AT(1) and ET(A) receptor blockade in a transgenic, angiotensin II-dependent, rat model.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Humans; Hypertension; Losartan; Phenylpropionates; Pyrimidines; Rats; Renin | 2000 |
Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Viscosity; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Imidazoles; Losartan; Mesenteric Arteries; Muscle Tonus; Perindopril; Phenylpropionates; Pyridines; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Splanchnic Circulation; Vascular Resistance; Vasodilation | 2000 |
Hemodynamic, renal, and endocrine responses to acute ET(A) blockade at different ANG II plasma levels.
Topics: Aldosterone; Angiotensin II; Animals; Creatinine; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Glomerular Filtration Rate; Hemodynamics; Infusions, Intravenous; Injections, Intravenous; Phenylpropionates; Protein Precursors; Pulmonary Circulation; Pyrimidines; Receptor, Endothelin A; Reference Values; Renin; Renin-Angiotensin System; Urodynamics; Vascular Resistance | 2001 |
Transient involvement of endothelin in hypertrophic remodeling of small arteries.
Topics: Angiotensin II; Animals; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hypertrophy; Mesenteric Arteries; Norepinephrine; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Time Factors; Vascular Resistance | 2001 |
Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Aortic Valve Stenosis; Atrial Natriuretic Factor; Endothelin Receptor Antagonists; Endothelins; Female; Gene Expression; Hydralazine; Hypertrophy, Left Ventricular; Norepinephrine; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A | 2002 |
Enalaprilat, losartan and LU 135252 in coronary blood flow regulation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Coronary Circulation; Enalaprilat; Female; Losartan; Male; Phenylpropionates; Pyrimidines; Swine | 2003 |